Interleukin-6: A Masterplayer in the Cytokine Network
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,General Medicine
Reference26 articles.
1. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA. 1985;82:5490–4.
2. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324:73–6.
3. Scheller J, Chalaris A, Schmidt-Arras D, S , Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–88.
4. Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J, : The soluble interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol. 2011;90:484–94.
5. Garbers C, Thaiss W, Jones G, Waetzig G, Lorenzen I, Guilhot F. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem. 2011;286:42959–70.
Cited by 260 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial;Thrombosis Research;2024-11
2. Analyze interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in dry eye and the therapeutic effect of cyclosporine A;World Journal of Clinical Cases;2024-09-06
3. IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3‐Led Ubiquitylation of GPX4;Advanced Science;2024-09-04
4. IL-6 and stroke recurrence in ischemic stroke;Biomarkers in Medicine;2024-09-04
5. SARS‐CoV‐2 coinfection in children with severe airway obstruction due to pulmonary tuberculosis;Pediatric Pulmonology;2024-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3